Focus Partners Wealth
NAGE icon

Focus Partners Wealth’s Niagen Bioscience NAGE Stock Holding History

Focus Partners Wealth’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.5K Sell
12,996
-2,524
-16% -$10.2K ﹤0.01% 2691
2026
Q1 		$15.5K Buy
15,520
+2,326
+18% +$12.6K ﹤0.01% 2624
2025
Q4 		$83.9K Buy
+13,194
New +$91.8K ﹤0.01% 2567
2025
Q3 		– Sell
-13,991
Closed -$202K – 2340
2025
Q2 		$202K Buy
13,991
+1,577
+13% +$15.6K ﹤0.01% 1878
2025
Q1 		$85.7K Buy
+12,414
New +$78K ﹤0.01% 1820

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Focus Partners Wealth's NAGE Position: Q2 2026 in Review

Focus Partners Wealth reduced its Niagen Bioscience (NAGE) stake by 16% in Q2 2026, selling an estimated $10.2K and leaving 12,996 shares worth $41.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2691.

Focus Partners Wealth first reported a position in NAGE in Q1 2025 and has held it in 5 quarters since. The position peaked at $202K in Q2 2025. 139 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • Focus Partners Wealth held 12,996 shares of Niagen Bioscience worth $41.5K as of Q2 2026.
  • Focus Partners Wealth sold 2,524 Niagen Bioscience shares in Q2 2026, an estimated $10.2K.
  • Niagen Bioscience made up ﹤0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #2691 holding.
  • Focus Partners Wealth first reported a position in Niagen Bioscience in Q1 2025 and has held it in 5 quarters since.
  • Focus Partners Wealth's Niagen Bioscience position peaked at $202K in Q2 2025.
  • 139 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.